Preemptive Kidney Transplantation in CKD Stage 5

Introduction to Preemptive Transplantation

The American College of Cardiology and other guideline societies recommend that patients with CKD stage 5 can and should be considered for preemptive kidney transplantation when appropriate criteria are met, and this approach is actually preferred when feasible 1

Patients must be at CKD stage 4 or early stage 5 (GFR <30 mL/min/1.73 m²) to allow adequate time for transplant evaluation and preparation, according to the American Journal of Kidney Diseases 3, 4
The American Journal of Kidney Diseases also recommends that patients should have no urgent uremic symptoms requiring immediate dialysis (no uremic pericarditis, encephalopathy, severe bleeding, refractory fluid overload, or uncontrolled hyperkalemia) 4, 2
Availability of a living donor or very short deceased donor waiting time is necessary, as preemptive transplantation requires timely organ availability, as stated by the American Journal of Kidney Diseases 5
Patients should have received comprehensive education about all kidney replacement therapy options during CKD stage 4, as recommended by the American Journal of Kidney Diseases 3, 4

Referral to nephrology must occur at least 1 year before anticipated need for renal replacement therapy to avoid "late referral" complications and allow adequate time for transplant evaluation, according to the American College of Cardiology and Praxis Medical Insights 1
The American Heart Association, as published in Circulation, states that transplant evaluation is a lengthy process requiring multiple assessments 6
The American Journal of Kidney Diseases recommends that living donor evaluation takes considerable time 5
Patients need time to assimilate information and make informed decisions, as stated by the American Journal of Kidney Diseases 3, 7

Preemptive transplantation avoids the complications and morbidity associated with dialysis initiation, including no exposure to dialysis-associated cardiovascular stress, as recommended by the American Journal of Kidney Diseases 4
Better preservation of residual kidney function is achieved with preemptive transplantation, according to Praxis Medical Insights 1
Improved quality of life without dialysis burden is possible with preemptive transplantation, as stated by the American Journal of Kidney Diseases 3, 4

The American College of Cardiology and Praxis Medical Insights recommend that evaluation should begin when GFR approaches 20 mL/min/1.73 m², rather than waiting until GFR <15 mL/min/1.73 m² 1
The American Journal of Kidney Diseases states that not all CKD stage 5 patients require dialysis before transplant, and this outdated approach denies patients the benefits of preemptive transplantation 5, 1
The American College of Cardiology and Praxis Medical Insights recommend that serum creatinine should not be relied upon solely, and eGFR should be calculated using validated equations (MDRD or CKD-EPI) to accurately assess kidney function and timing 1
The American Journal of Kidney Diseases recommends that preemptive transplant should not proceed if the patient has active uremic symptoms, as these require dialysis stabilization first 4, 2

The American Journal of Kidney Diseases recommends that patients should still receive education about all dialysis modalities and have contingency access planning (arteriovenous fistula evaluation for hemodialysis or peritoneal dialysis catheter readiness) in case transplantation is delayed or complications arise 3, 4

The American Heart Association, as published in Circulation, recommends obtaining resting transthoracic echocardiogram and 12-lead ECG as baseline cardiac assessment for kidney transplant candidates 6
Patients meeting all low-risk criteria (age <60 years, no diabetes/cerebrovascular disease/peripheral artery disease, dialysis duration <5 years, no evidence of silent MI on ECG) do not require further cardiac stress testing before transplant evaluation, according to the American Heart Association and Circulation 6